Recent Advances in Biomedical Applications of Magnetic Nanomaterials
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 255
Special Issue Editors
Interests: magnetic nanoparticles; magnetic hyperthermia; plasmonic nanoparticles; vibrational spectroscopy; Surface Enhanced Raman Spectroscopy (SERS); liposomes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Magnetic nanoparticles (MNPs) have emerged as promising candidates for a wide array of biomedical applications due to their unique responsiveness to external magnetic fields, which enables remote control and manipulation.
In recent years, extensive research efforts have been dedicated to exploring the applications of magnetic nanoparticles (MNPs) in biomedical fields, including their use as contrast agents in magnetic resonance imaging (MRI), or more recently using the magnetic particle imaging technique. Additionally, MNPs have shown promise in cancer therapy through magnetic hyperthermia, where they are subjected to radiofrequency magnetic fields to induce heating for therapeutic purposes. Moreover, the fabrication of hybrid nanostructures by combining MNPs with polymers, fluorophores, liposomes, and plasmonic or silica shells has opened up new possibilities for both diagnosing and treating medical conditions. These multifaceted nanomaterials offer the unique capability of remote control over their positioning and activation, positioning them as a highly investigated class of theranostic materials.
We aim for this Special Issue, titled "Recent Advances in Biomedical Applications of Magnetic Nanomaterials", to provide a platform for researchers to share their latest experimental and theoretical findings related to the development and application of magnetic nanomaterials in the medical field, where we welcome both reviews and research papers focused on distinct aspects of medical applications of MNPs.
Prof. Dr. Constantin Mihai Lucaciu
Prof. Dr. Yunn-Hwa Ma
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- magnetic hyperthermia
- magnetoplasmonic nanoparticles
- targeted drug delivery
- magnetoliposomes
- magnetic resonance imaging
- magnetic particle imaging
